Rapid purification of recombinant proteins by protein nanoparticle crosslinking and light-responsive nanobodies

通过蛋白质纳米颗粒交联和光响应纳米抗体快速纯化重组蛋白

基本信息

  • 批准号:
    2040749
  • 负责人:
  • 金额:
    $ 36.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-15 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

The increasing demand for new protein-based drugs has accelerated the need for more effective processes for their large-scale production. Access to cost-effective and highly efficient protein purification processes is among the most pressing challenges. This project will address the persistent challenges in protein purification by developing an innovative strategy based on reversible, light-responsive protein capture. Blue and red light can be used to control protein binding, precipitation, and recovery of the required nanoscaffold molecules. This strategy has many operational advantages over purification by conventional chromatographic methods as well as other affinity-based methods. The light-responsive purification platform can also be tailored to capture virtually any native protein of interest. The outcomes of this project have the potential to transform industrial protein purification processes by eliminating the need for chromatography, the cost of which often exceeds 50% of the overall protein production costs. The efficiency gains are expected to substantially reduce the cost of therapeutic proteins and positively impact the health and wellbeing of the nation. Engagement of high school students in summer research opportunities, combined with extended research opportunities for undergraduate students, will provide valuable training opportunities and help develop the future STEM workforce.The overall goal of the proposal is to develop a new affinity precipitation platform for recombinant protein purification by combining state-of-the-art optogenetic tools with nanoscaffold-based affinity precipitation into a new transformative framework for native protein purification. Conditional nanobodies will be optogenetically activated by blue light to create switchable target protein binding properties. A red light-responsive domain will be inserted in the optobody-modified nanoscaffold to enable its recovery. The project objectives include (i) design optimal optobodies for blue-light switchable antigen binding, (ii) decorate the nanocages with different capturing optobody motifs for target protein capture and release, (iii) co-decorate the nanocages for red light-activated aggregation, and (iv) evaluate the target protein purification and nanocage regeneration efficiency. The protein purification platform is operationally simple since protein capture/release and nanoscaffold recovery can be independently controlled using two orthogonal blue and red light triggers. Both the nanobody motif and the light-responsive protein elements are highly modular, enabling this purification strategy to be used to target many native proteins of interest. This platform can be adapted into a high-throughput format owing to the ease of operation, compatibility for miniaturization, elimination of chromatography, and the flexibility and largely target-independent process.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
对新型蛋白质药物的需求不断增加,加速了对更有效的大规模生产工艺的需求。获得具有成本效益和高效的蛋白质纯化工艺是最紧迫的挑战之一。该项目将通过开发一种基于可逆、光响应蛋白捕获的创新策略来解决蛋白质纯化方面的持续挑战。蓝光和红光可用于控制蛋白质结合、沉淀和所需纳米支架分子的回收。与传统的色谱方法和其他基于亲和度的方法相比,这种方法具有许多操作上的优势。光响应纯化平台也可以定制捕获几乎任何感兴趣的天然蛋白质。该项目的成果有可能通过消除对色谱的需求来改变工业蛋白质纯化过程,色谱的成本通常超过蛋白质生产总成本的50%。效率的提高预计将大大降低治疗性蛋白质的成本,并对国民的健康和福祉产生积极影响。高中生参与暑期研究机会,结合本科生的扩展研究机会,将提供宝贵的培训机会,并有助于培养未来的STEM劳动力。该提案的总体目标是通过将最先进的光遗传学工具与基于纳米支架的亲和沉淀相结合,开发一种新的重组蛋白纯化亲和沉淀平台,形成一种新的天然蛋白纯化变革框架。条件纳米体将被蓝光光遗传学激活,以产生可切换的靶蛋白结合特性。红光响应域将被插入到光体修饰的纳米支架中,以使其恢复。该项目的目标包括(i)设计用于蓝光可切换抗原结合的最佳光体,(ii)用不同的捕获光体基元装饰纳米笼以捕获和释放靶蛋白,(iii)共同装饰纳米笼以进行红光活化聚集,以及(iv)评估靶蛋白纯化和纳米笼再生效率。蛋白质纯化平台操作简单,因为蛋白质捕获/释放和纳米支架回收可以使用两个正交的蓝光和红光触发器独立控制。纳米体基序和光响应蛋白元件都是高度模块化的,这使得这种纯化策略可以用于靶向许多感兴趣的天然蛋白。由于易于操作,兼容小型化,消除色谱,以及灵活性和很大程度上与目标无关的过程,该平台可以适应为高通量格式。该奖项反映了美国国家科学基金会的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wilfred Chen其他文献

Functional assembly and characterization of a modular xylanosome for hemicellulose hydrolysis in yeast
用于酵母半纤维素水解的模块化木糖体的功能组装和表征
  • DOI:
    10.1002/bit.24609
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    S. Srikrishnan;Wilfred Chen;N. D. Da Silva
  • 通讯作者:
    N. D. Da Silva
Peptide-Delivered Molecular Beacons Poliovirus-Infected Cells via TAT Quantitative Detection of Use of Flow Cytometry for Rapid
通过 TAT 快速定量检测流式细胞仪对脊髓灰质炎病毒感染细胞进行肽递送分子信标
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Yates;Wilfred Chen;D. Sivaraman;Hsiao;A. Mulchandani
  • 通讯作者:
    A. Mulchandani
Engineering a high‐affinity scaffold for non‐chromatographic protein purification via intein‐mediated cleavage
通过内含肽介导的切割设计用于非层析蛋白质纯化的高亲和力支架
High‐efficiency affinity precipitation of multiple industrial mAbs and Fc‐fusion proteins from cell culture harvests using Z‐ELP‐E2 nanocages
使用 Z-ELP-E2 纳米笼对细胞培养物中的多种工业 mAb 和 Fc 融合蛋白进行高效亲和沉淀
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    A. Swartz;Xuankuo Xu;Steven J Traylor;Z. Li;Wilfred Chen
  • 通讯作者:
    Wilfred Chen
Customizable Biopolymers for Heavy Metal Remediation
用于重金属修复的可定制生物聚合物
  • DOI:
    10.1007/s11051-005-5132-y
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J. Kostal;G. Prabhukumar;U. L. Lao;Alin Chen;M. Matsumoto;A. Mulchandani;Wilfred Chen
  • 通讯作者:
    Wilfred Chen

Wilfred Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wilfred Chen', 18)}}的其他基金

Collaborative Research: NSF/MCB: Repurposing metabolite-responsive aptamers for real-time sensing and dynamic control of Cas6-mediated metabolon assembly
合作研究:NSF/MCB:重新利用代谢物响应适体,用于 Cas6 介导的代谢物组装的实时传感和动态控制
  • 批准号:
    2317398
  • 财政年份:
    2023
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Standard Grant
Logic-gated pro-MMP activation for tumor-specific motility in nanocarriers
纳米载体中肿瘤特异性运动的逻辑门控 MMP 前体激活
  • 批准号:
    2220667
  • 财政年份:
    2023
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Continuing Grant
Collaborative Research: Synthetic methane fixation cascades based on engineered membrane vesicles for biofuel cell applications
合作研究:基于工程膜囊泡的合成甲烷固定级联,用于生物燃料电池应用
  • 批准号:
    2221893
  • 财政年份:
    2022
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Standard Grant
Collaborative Research: Synthetic CRISPR-Cas6 endonucleases for dynamic control of cellular phenotypes in yeast
合作研究:用于动态控制酵母细胞表型的合成 CRISPR-Cas6 核酸内切酶
  • 批准号:
    2013991
  • 财政年份:
    2020
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Standard Grant
Collaborative Research: Dynamic degradation of proteins by ubiquitination provides a novel therapeutic for controlling elevated protein levels
合作研究:通过泛素化动态降解蛋白质为控制蛋白质水平升高提供了一种新的治疗方法
  • 批准号:
    1803008
  • 财政年份:
    2018
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Standard Grant
Collaborative Research: Redirecting cellular metabolism via synthetic toehold-gated dCas9 regulators
合作研究:通过合成的门控 dCas9 调节器重定向细胞代谢
  • 批准号:
    1817675
  • 财政年份:
    2018
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Standard Grant
Biochemical and Molecular Engineering XX Conference
生化与分子工程XX会议
  • 批准号:
    1739060
  • 财政年份:
    2017
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Standard Grant
Repurposing the CRISPR-Cas9 system for dynamic control of cellular metabolism
重新利用 CRISPR-Cas9 系统动态控制细胞代谢
  • 批准号:
    1615731
  • 财政年份:
    2016
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Continuing Grant
Collaborative Research: Advanced biomanufacturing of functional bionanoparticles for biomedical engineering applications
合作研究:用于生物医学工程应用的功能性生物纳米颗粒的先进生物制造
  • 批准号:
    1604925
  • 财政年份:
    2016
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Standard Grant
Design of Multi-Functional SplitCore HBV Capsids for Precisely Controlled Multi-siRNA Delivery in Cancer Therapeutics
设计多功能 SplitCore HBV 衣壳,用于癌症治疗中精确控制的多 siRNA 递送
  • 批准号:
    1609621
  • 财政年份:
    2016
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Continuing Grant

相似国自然基金

里氏木霉纤维素酶cbh基因表达系统调控蛋白分析
  • 批准号:
    30670056
  • 批准年份:
    2006
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

SBIR Phase I: Hemagglutinin-specific affinity capture membrane for rapid purification of influenza vaccines
SBIR 第一阶段:用于快速纯化流感疫苗的血凝素特异性亲和捕获膜
  • 批准号:
    10007691
  • 财政年份:
    2020
  • 资助金额:
    $ 36.96万
  • 项目类别:
Rapid Ligand Pairing Strategy to Simplify Diagnostic Immunoassay Assembly
简化诊断免疫测定组装的快速配体配对策略
  • 批准号:
    8492614
  • 财政年份:
    2013
  • 资助金额:
    $ 36.96万
  • 项目类别:
Development of hantavirus vaccine and rapid diagnosis kit by using soluble recombinant envelope glycoproteins
可溶性重组包膜糖蛋白汉坦病毒疫苗及快速诊断试剂盒的研制
  • 批准号:
    13556046
  • 财政年份:
    2001
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
RAPID DETOXIFICATION OF COCAINE BY BUTYRYLCHOLINESTERASE
丁酰胆碱酯酶对可卡因的快速解毒
  • 批准号:
    2593410
  • 财政年份:
    1998
  • 资助金额:
    $ 36.96万
  • 项目类别:
RAPID DETOXIFICATION OF COCAINE BY BUTYRYLCHOLINESTERASE
丁酰胆碱酯酶对可卡因的快速解毒
  • 批准号:
    6174747
  • 财政年份:
    1998
  • 资助金额:
    $ 36.96万
  • 项目类别:
RAPID DETOXIFICATION OF COCAINE BY BUTYRYLCHOLINESTERASE
丁酰胆碱酯酶对可卡因的快速解毒
  • 批准号:
    2898234
  • 财政年份:
    1998
  • 资助金额:
    $ 36.96万
  • 项目类别:
Rapid and large scale plant-based production of catalytic nerve agent bioscavenge
催化神经毒剂生物清除剂的快速大规模植物基生产
  • 批准号:
    7487882
  • 财政年份:
  • 资助金额:
    $ 36.96万
  • 项目类别:
Rapid and large scale plant-based production of catalytic nerve agent bioscavenge
催化神经毒剂生物清除剂的快速大规模植物基生产
  • 批准号:
    7689885
  • 财政年份:
  • 资助金额:
    $ 36.96万
  • 项目类别:
Rapid and large scale plant-based production of catalytic nerve agent bioscavenge
催化神经毒剂生物清除剂的快速大规模植物基生产
  • 批准号:
    8117145
  • 财政年份:
  • 资助金额:
    $ 36.96万
  • 项目类别:
Rapid and large scale plant-based production of catalytic nerve agent bioscavenge
催化神经毒剂生物清除剂的快速大规模植物基生产
  • 批准号:
    7920100
  • 财政年份:
  • 资助金额:
    $ 36.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了